Cargando...

Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots

Intermittent androgen deprivation therapy (IADT) is now being increasingly opted by the treating physicians and patients with prostate cancer. The most common reason driving this is the availability of an off-treatment period to the patients that provides some relief from treatment-related side-effe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Asian J Urol
Autor principal: Abrahamsson, Per-Anders
Formato: Artigo
Lenguaje:Inglês
Publicado: Second Military Medical University 2017
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5772839/
https://ncbi.nlm.nih.gov/pubmed/29387553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajur.2017.04.001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!